baber/WOPTO huggingface dataset:
Patent NZ-330190-A (NZ)
Title: Socket, for a hinge pin, and a cabinet, for holding electronic equipment or wiring systems
Inventor: DORLAS HENDRIK CHRISTIAAN
IPC: A47B47/02
Filed: 1998-04-15
Abstract: A hinge pin socket 90, for a cabinet, comprises, in the plane of rotation of the hinge, a static part 91 and a moveable part 92, which in a first position (Fig.8B) defines a hinge pin retaining enclosure 90.  The moveable part 92 is resiliently biased (spring 96) toward the first position but has a permitted movement relative to the first position to open the enclosure (Fig. 8A) to enable entry or exit of the hinge pin.  The moveable part may be formed with a slot to accommodate a protrusion 95 on the static part 91 so that the protrusion and the slot together define the available slidable movement of part 92.  The moveable part 92 may have a flat bearing surface 93 to complete the enclosure 90 so that with a hinge pin in position within the enclosure pressure against the bearing surface does not encourage sliding movement of part 92.
Patent NZ-502809-A (NZ)
Title: Compositions and methods for filling gelatin capsules comprising PEG (200-500), carboxylic polymer, glycerol, an oleaginous material and an alkoxylated fatty amine for use in cosmetics and paint balls
Inventor: REYNOLDS WILLIAM
IPC: A61K8/81
Filed: 1998-07-15
Abstract: Disclosed are fill compositions suitable for carrying pigment and encapsulation within gelatin capsules comprising: (a) a polyoxyalkylene glycol having a mean molecular weight of from about 200-500; (b) glycerol; (c) water; (d) an oleaginous material; (e) a carboxylic copolymer; and (f) a neutralizing agent for the carboxylic polymer in an amount effective to neutralize at least about 75% of the carboxylic acid groups on the polymer. Also disclosed are gelatin capsules containing such compositions and methods for preparing the fill compositions.
Patent NZ-504571-A (NZ)
Title: Access and traffic coverage using variable-timing cell-site modems in large CDMA cell sizes
Inventor: CHAUDRY SHAHID R
IPC: H04B7/26
Filed: 2000-05-16
Abstract: To provide code division multiple access (CDMA) access availability to a large cell area and to establish traffic channels, the group of cell site modems are configured to look for access attempts generated in respective complete and /or sectorized circular or annular shaped areas centred at the center of the cell area, the areas collectively covering the cell area.  Each cell site modem has a local clock, the local clock of a first of the cell site modems being synchronized with standard network time, and the local clocks of the other cell site modems being offset by a respective delay with respect to the standard network time which causes the cell site modem to search within its respective annular shaped area.  A cell site modem is also made available as a traffic cell site modem and is operable to have its traffic acquisition search window centred at a location of the access attempt.  Alternatively, a plurality of traffic cell site modems may be provided, each having dedicated circular or annular coverage areas within the cell.  The traffic cell site modems also preferably have a local clock which may be synchronized, either to a standard network time, or to a respective delay which causes it to search in its respective area.  The handing off process between circular and annular shaped traffic coverage areas is detailed.
Patent NZ-505255-A (NZ)
Title: Syringe pump with force sensor on plunger pusher and/or retainers that are moved laterally and axially across front surface of plunger head
Inventor: FORD ANDREW JOHN
IPC: A61M5/20
Filed: 2000-06-19
Abstract: An alternative syringe pump and method of operation that is adapted to receive a syringe of the kind having a plunger movable along a barrel is described.  The pump includes a plunger head retainer mechanism having a forwardly-facing surface adapted to engage a rear surface of the plunger head and to apply a forwardly-directed force to the plunger.  The plunger head retainer mechanism includes a force sensor means responsive to force exerted on the plunger head by the retainer mechanism during displacement of the plunger.  The retainer mechanism moves the plunder head and force sensor means together into contact with one another. The front of the pump is shown in Fig. 1.  It includes an outer housing 1 with a recess 2 on its front surface shaped to receive a conventional syringe 3.
Patent NZ-506389-A (NZ)
Title: Pharmaceutical compositions containing epothilone which can be optionally lyophilised
Inventor: VAN HOOGEVEST PAUL
IPC: A61K9/19
Filed: 1999-02-03
Abstract: A pharmaceutical infusion concentrate comprises an epothilone and a pharmaceutically acceptable organic or aqueous solvent.  Also described is a pharmaceutical formulation comprising an epothilone and a pharmaceutically acceptable organic or aqueous solvent in the absence of a surfactant having an HLB value of 10 or above. A lyophilized composition contains an epothilone and mannitol or a cyclodextrin.
Patent NZ-514848-A (NZ)
Title: Radiolabelled neutrokine alpha protein
Inventor: YU GUO-LIANG
IPC: A61P37/06
Filed: 1996-10-25
Abstract: An  isolated neutrokine-a polypeptide is  radiolabeled and  comprises the amino acid of SEQ ID NO:2. The radiolabel can  be  selected from the group consisting  of  131I,  125I 121I, 14C, 35S, 3H, 112In and 99mTc.
Patent NZ-515678-A (NZ)
Title: Human GIL-19/AE289 proteins and polynucleotides encoding same
Inventor: JACOBS KENNETH
IPC: C07K16/24
Filed: 2000-04-28
Abstract: Novel human GIL-19/AE289 protein is disclosed which shows a high degree of homology to interleukin-10 (IL-10). Polynucleotides encoding such proteins are also enclosed. Further disclosed is the use of antagonists (e.g. an antibody) of said human GIL-19/AE289 protein to treat/prevent autoimmune diseases.
Patent NZ-518765-A (NZ)
Title: Induction of mucosal immunity by vaccination via the skin route
Inventor: CHEN DEXIANG
IPC: A61P31/04
Filed: 2000-11-09
Abstract: Described is a vaccine composition suitable for delivery into or across the skin of a vertebrate subject. This composition comprises an antigen or a nuclei acid encoding antigen; an ADP-ribosylating toxin as an adjuvant; and an oligonucleotide containing a CpG motif. The vaccine composition is disclosed to be used in generating an immune response at a mucosal surface, and for the treatment or preclusion of a disease caused by a pathogen that enters the body or a vertebrate subject via a mucosal surface. A dosage container comprising the vaccine composition for use in a needleless syringe powder injection device is also described.
Patent NZ-518890-A (NZ)
Title: Route guidance for vehicle
Inventor: BAIL GUNTHER
IPC: A63B55/60
Filed: 2000-10-31
Abstract: A self-propelling vehicle and associated method for controlling it, which consists of driving along a selected route from a starting point to a destination, whereby the vehicle receives position signals from a positioning system and stores said signals in a data memory. The vehicle first receives an associated current position signal from the positioning system and at a point of departure when the vehicle subsequently and automatically drives along exactly the same selected route. Said signal is compared to the position of the starting point. If the positions do not match, the evaluation device calculates the direction towards and the distance to the starting point, whereupon the vehicle drives along this route. The direction and the distance to the next stored position are subsequently calculated using successively received current position data.
Patent NZ-522927-A (NZ)
Title: Overvoltage protection using both varistors and spark-gap arresters
Inventor: KOUWENHOVEN JACOBUS THEODORUS
IPC: H02H9/04
Filed: 2001-07-09
Abstract: A system for surge protection of an object, comprising a supply unit which is connected to the secondary output of an external transformer. The secondary windings (1) of the external transformer are coupled in a star configuration, the star point of the transformer being connected to a downstream neutral conductor (7) and an earth electrode provided near to the transformer. In the supply unit, at least one phase conductor (6) is connected to the neutral conductor (7) by means of a surge protective device of a first type (4), and the neutral conductor (7) is connected to an earth electrode (5) provided near to the supply unit by means of a surge protective device of a second type (9). The surge protective device of the first type (4) comprises a voltage dependent resistor or varistor and the surge protective device of the second type (9) comprises a lightning current arrester or spark gap element.
Patent NZ-523282-A (NZ)
Title: Synthetic grass with resilient granular top surface layer
Inventor: PREVOST JEAN
IPC: E01C13/08
Filed: 2001-06-21
Abstract: A synthetic grass assembly for installation on a supporting substrate, the assembly comprising: - a pile fabric with a flexible sheet backing and a plurality of upstanding synthetic ribbons of a selected length, the ribbons extending upwardly from an upper surface of the backing, - an infill layer of particulate material disposed interstitially between the upstanding ribbons upon the upper surface of the backing and of a depth less than the length of the ribbons, the particulate material selected from hard and resilient granules, wherein the infill comprises: - a bottom course of intermixed hard and resilient granules disposed upon the upper surface of the backing, and - a top surface substantially exclusively of resilient granules disposed upon the bottom course, an upper portion of the synthetic ribbons extending upwardly from a top surface of the top course.
Patent NZ-525471-A (NZ)
Title: Plant container liners
Inventor: JUST PERRY
IPC: A01G9/02
Filed: 2003-04-24
Abstract: A liner for a plant container includes one or more sheets of partially compressed, dried or at least substantially dry, reconstitutible sphagnum moss. The liner is formed into a three dimensional shape having a top opening and one or more walls extending in an upstanding configuration toward the opening, the walls having a body and top edges defined along the top opening. The top edges are compressed to a lesser degree that the body of the walls. A blank for forming the liner and a method of forming the liner or the blank is also disclosed. (62) Divided out of 508156
Patent NZ-526110-A (NZ)
Title: Method and device for storing natural casings and deep- frozen natural casings
Inventor: WOIWODE OLIVER
IPC: A22C15/00
Filed: 2001-11-30
Abstract: The invention relates to a method for storing natural casings, especially hog casings and sheep casings, for packaging meat and sausages, according to which the natural casings are deep-frozen to at least 50 DEG C after processing. The invention also relates to deep-frozen casings and to a device for holding natural casings that are placed on rod-shaped support devices. Said device comprises two supports (14), and, interlinked therewith, a plurality of insertion elements (16, 18) into which receiving devices (20) are inserted. Every receiving device (20) has holding elements (22) onto which the rod-shaped support devices (24) are placed. The gathered natural casings are disposed on the support devices (24). The frame that is loaded with the natural casings (26) is then transported to a cooling or freezing installation for deep- freezing the natural casings.
Patent NZ-527569-A (NZ)
Title: System for and method of performing evaluation techniques on a log or round timber
Inventor: WANG XIPING
IPC: G06F15/00
Filed: 2002-01-30
Abstract: To evaluate a round timber, a stress wave is introduced into the timber and its speed through the timber is measured by a sensor attached to the timber. The calculated dynamic Modulus of Elasticity (MOE) and the measured length and average diameter of the timber are received by one or more input devices connected to an analysis module which calculates a "predictive" MOE based on the dynamic MOE and the length and diameter of the timber.
Patent NZ-531527-A (NZ)
Title: A composition consisting aqueous free nucleic acid and anti-inflammatory/immuno-suppressive agent for achieving persistent transgene expression
Inventor: LU PATRICK
IPC: C12N9/99
Filed: 2000-12-27
Abstract: Non-inflammatory vector compositions suitable for repeated transgene delivery and that result in persistent transgene expression are disclosed. The compositions are non-inflammatory, the present compositions are suitable for readministration and do not induce expression-limiting immune or inflammatory responses. Thus, these compositions are useful in methods of repeated administration to achieve persistent transgene expression, and are especially suited to treating genetic, acquired and inflammation-associated conditions. Particularly disclosed is a non-inflammatory vector composition, comprising (i) aqueous free nucleic acid that encodes a gene product and (ii) an anti-inflammatory compound selected from a steroid anti-inflammatory agent and a non- steroid anti-inflammatory agent (NSAID). (62) Divided out of 519756
Patent NZ-532118-A (NZ)
Title: A device for holding an additive and to add it to a container, a container and a method of making a container
Inventor: STERN LEIF
IPC: B65D81/32
Filed: 2001-11-19
Abstract: A compartment for holding an additive and including means to add the additive component to container. It comprises an upper portion, a lower frangible portion to form a compartment together with the upper portion and a cutter inside the compartment. The lower frangible portion is attached to a container. The application also refers to a container having such a compartment and a method of making such a container and mounting the compartment.
Patent NZ-532434-A (NZ)
Title: Polymorphic B form of 3-(cyclopropylmethoxy)-4-[4-(methylsulfonyl)phenyl]-5,5-dimethyl-5H-furan-2-one
Inventor: JUN CHEN
IPC: A61K47/18
Filed: 2001-02-05
Abstract: Polymorphic B Form of 3-(cyclopropylmethoxy)-4-[4-(methylsulfonyl)phenyl]-5,5-dimethyl-5H-furan-2-one characterized by the following parameters: (62) Divided out of 520707
Patent NZ-535083-A (NZ)
Title: A zero-order controlled release pharmaceutical dosage form for oral administration
Inventor: LERNER ITZHAK E
IPC: A61K9/22
Filed: 2003-03-03
Abstract: A zero-order release pharmaceutical dosage form for oral administration to a patient comprising a core tablet sheathed in an annular body of compressed powder or granular material is provided. A preferred embodiment of the zero-order release pharmaceutical dosage form is a solid pharmaceutical dosage form which reduces contact of the active ingredient in solid form with the mucosa lining the gastrointestinal tract, which is particularly advantageous for delivering an ulcerative drug. A process for making the zero-order release pharmaceutical dosage form is also provided. Particularly disclosed is a pharmaceutical dosage form for oral administration to a patient comprising a core tablet having two axial surfaces containing an active ingredient, at least 19% of hydrogel excipient, and a non-hydrogel excipient, the core being sheathed in an annular body, itself having two axial surfaces, of compressed powder or granular material, whereby the annular body controls the drug-releasing surface area of the two axial surfaces of the core tablet to between 0.4 mm2 and 265 mm2 and whereby the dosage form releases the active ingredient from the core tablet at a rate in the range of from 3% per hour to 12% per hour over a period of seven hours or more.
Patent NZ-539506-A (NZ)
Title: Continuous process for the preparation of fructopyranose sulfamate derivatives and topiramate
Inventor: ADKINS THOMAS W
IPC: C07D493/02
Filed: 2003-10-27
Abstract: The disclosure is directed to a continuous process for the preparation of fructopyranose sulfamate derivatives of the general formula (I) wherein R1, R3, R4, R5, R6 and X are as defined in the specification. The disclosure is further directed to a continuous process for the preparation of Topiramate.
Patent NZ-540050-A (NZ)
Title: Pyrrolobenzodiazepines having activity against cancer cell lines
Inventor: THURSTON DAVID EDWIN
IPC: A61P35/00
Filed: 2003-11-14
Abstract: Pyrrolobenzodiazepine compounds of formula (I) and salts, solvates, chemically protected forms, and prodrugs thereof, which have an activity against cancer cell lines are disclosed, wherein R2 is selected from: an optionally substituted napthyl group; an optionally substituted thiophenyl or furanyl group; and a phenyl group substituted by: one or more chloro or fluoro groups; an ethyl or propyl group; a 4-t-butyl group; a 2-methyl group; or two methyl groups in the 2- and 6- positions, and wherein the other variables shown in formula (I) are as defined in the specification.
Patent NZ-540841-A (NZ)
Title: Tetracyclic 3-substituted indoles having serotonin receptor affinity
Inventor: RAMAKRISHNA VENKATA SATYA NIROGI
IPC: C07D/
Filed: 2003-12-16
Abstract: Disclosed are substituted tetracyclic 3-substitued indoles of the general formula (I) wherein the substituents are described within the specification. Also disclosed is the process for making the above compounds and intermediates.
Patent NZ-546088-A (NZ)
Title: Combination therapy for the treatment of ocular neovascular disorders using a PDGF antagonist and a VEGF antagonist
Inventor: SHIMA DAVID
IPC: A61K45/00
Filed: 2004-08-26
Abstract: Disclosed is a pharmaceutical composition comprising: (i) a PDGF antagonist; (ii) a VEGF antagonist; and (iii) a pharmaceutically acceptable carrier, wherein the PDGF antagonist is a nucleic acid molecule, an aptamer, an antisense RNA molecule, a ribozyme, or an RNAi molecule, the VEGF antagonist is an antibody or antibody fragment, and the PDGF antagonist and the VEGF antagonist are present in an amount sufficient to suppress a neovascular disorder in a patient.
Patent NZ-546159-A (NZ)
Title: Carbamoyl-type benzofuran derivatives
Inventor: KAWAGUCHI TAKAYUKI
IPC: C07D405/14
Filed: 2004-09-24
Abstract: Disclosed is a compound of formula [1], with substituents as defined in the specification, which is useful as an inhibitor of activated blood coagulation factor X (FXa) for treating thrombosis.
Patent NZ-549645-A (NZ)
Title: Sprayless surface cleaner
Inventor: STUDEBAKER ROY
IPC: A47L11/30
Filed: 2005-01-10
Abstract: A bar jet assembly formed of a base plate having a cleaning fluid discharge chamber (112) communicating with a cleaning fluid input surface and a discharge slot in a cleaning fluid output surface; and a pair of cover plates coupled to the fluid output surface of the base plate and forming therebetween an inclined cleaning fluid discharge orifice (116) communicating with the base plate discharge slot.
Patent NZ-551151-A (NZ)
Title: Mailing label having a signature section and method of using the same
Inventor: SCHENCK KAREN E
IPC: G06Q10/00
Filed: 2004-09-30
Abstract: A mail processing system for processing a mailing label 10 comprising an informational surface comprised of a plurality of discrete informational sections 12 16 18 including an indicia section 16 disposed on the informational surface and a signature section 12 disposed on the informational surface; the mail processing system comprising: a portable data collection device comprising a scanner configured to simultaneously scan the informational surface of the mailing label and link two or more informational sections.
Patent NZ-553495-A (NZ)
Title: Mesh and methods and apparatus for forming mesh and link elements
Inventor: HORSHAM KAYNE BRUCE
Filed: 2007-02-27
Abstract: A method of moulding a functional link element to a mesh of linked elements is disclosed. The functional link element is of a different form to the linked elements and has a functional element formed on it (2611), and the mesh has at least one linkage point. The linkage point of the mesh (2603, 2605) is provided to a mould (2601) and a mould cavity (2609) is associated with the linkage point. Material is injected to the cavity to mould the functional link element so that it is linked to the mesh at the linkage point.
Patent NZ-554970-A (NZ)
Title: Storage-stable aqueous composition comprising a magnesium compound and l-carnitine
Inventor: HOPF GUNTER
IPC: A23L33/00
Filed: 2007-05-04
Abstract: Disclosed is a storage-stable aqueous or gel-like composition or solution comprising a magnesium compound selected from a magnesium salt or a magnesium complex of an amino acid compound, and L-carnitine, and the use thereof for the preparation of a medicament for supporting metabolism, in particular in muscle tissue, and for supporting muscle structure, and its use as food supplement or in the veterinary sector as animal feed additive, in particular for horses, poultry, pigeons, pigs, cattle, sheep and camels.
Patent NZ-560638-A (NZ)
Title: A method of financial coaching
Inventor: ROBINSON ROY PETER
IPC: G06Q40/00
Filed: 2007-08-14
Abstract: An integrated system for the financial coaching of one or more users is provided. The system includes: (i) a means for establishing expenditure goals over one or more desired time periods and relating to one or more expenditure categories, (ii) a means for electronically collecting into a database actual expenditure in each expenditure category, during each desired time period, (iii) a means for totalling the actual expenditure amounts within each expenditure category, (iv) a means for comparing the actual expenditure total to the established expenditure goal for each expenditure category, and (v) a means for preparing and sending an electronic message to the user, to provide feedback to the users, as to what their actual expenditure is in relation to the established expenditure goal in each expenditure category.
Patent NZ-560927-A (NZ)
Title: Compositions comprising dehydrated micro-organisms mixed with larger particles to increase viability
Inventor: DERRIEU GUY
IPC: A61K9/42
Filed: 2006-02-06
Abstract: Disclosed is a dry composition having a water activity lower than 0.3 comprising between 1 and 80% w/w revivable dehydrated microscopic-sized eukaryotic or prokaryotic unicellular organisms, characterised in that it further comprises between 20 and 99% w/w dietary or medicated particles containing vitamins, trace elements, amino acids, sugars, minerals or the salts thereof, carriers or vegetable flours, alone or in a mixture, said particles being distributed within a particle-size range lower than 2,000 micrometers, at least 50% of which have a mean diameter greater than 250 micrometers.
Patent NZ-570844-A (NZ)
Title: Therapeutic piperazines as PDE4 inhibitors
Inventor: KEENAN TERENCE P
IPC: A61K31/495
Filed: 2007-02-27
Abstract: Disclosed are piperazine compounds represented by general formula (I), or pharmaceutically acceptable salts thereof, wherein is Z is a di-alkoxy substituted phenyl. Also disclosed is the use of the compounds of general formula (I) for improving cognitive function.
Patent NZ-574620-A (NZ)
Title: Salts of {1-methyl-5-[2-(5-trifluoromethyl-1H-imidazol-2-yl)-pyridin-4-yloxy]-1H-benzoimidazol-2-yl}-(4-trifluromethyl-phenyl)amine
Inventor: GULLAPALLI RAMPURNA
IPC: A61K31/4439
Filed: 2007-08-30
Abstract: Disclosed is a salt of {1-methyl-5-[2-(5-trifluoromethyl-1H-imidazol-2-yl)-pyridin-4-yloxy]-1H-benzoimidazol-2-yl}-(4-trifluoromethyl-phenyl)amine selected from the group consisting of acetate, tosylate, succinate, lactate, malate, sulfate, maleate, citrate, hydrochloride, phosphate, ethanesulfonate, and methanesulfonate, or a solvate and/or hydrate thereof. The salt is useful for treating cancer and inhibiting angiogenesis.
Patent NZ-576780-A (NZ)
Title: Thiophene analogues for the treatment or prevention of flavivirus infections
Inventor: CHAN CHUN KONG LAVAL
IPC: A61K31/4196
Filed: 2007-11-15
Abstract: Disclosed is 5-(3,3-dimethyl-but -1-ynyl )-3-[(trans-4-hydroxy-cyclohexyl)-(trans-4-methylcyclohexanecarbonyl)-amino]-thiophene-2-carboxylic acid or a pharmaceutically acceptable salt thereof. A composition comprising this compound, pegylated interferon-alpha and ribavirin is also disclosed. Use of the composition for treating hepatitis C viral infection is also disclosed.